Topical therapy for cervical precancer treatment

The purpose of this study is to assess the acceptability of a topical, self- or provider-administered, intravaginal therapy as primary or adjuvant (additional) treatment for cervical precancer among men and women in Kenya. Through questionnaires and in-depth interviews with women and men receiving cervical cancer care and medical care at participating facilities, respectively, we hope to understand how women and men regard the acceptability and potential barriers to topical treatments, which may be used to improve precancer treatment in Kenya and other countries.